Team NEMO: A simple treatment to reduce the activity of multiple sclerosis

A ten-year study carried out by 36 research centers in France, including CR2TI's NEMO team, shows that high-dose vitamin D supplementation reduces multiple sclerosis progression at an early stage

This study, published in the Journal of the American Medical Association (JAMA) and highlighted in Le Figaro magazine, demonstrates that vitamin D effectively slows the progression of multiple sclerosis, an effect suspected since studies on mice in 2005.

Mis à jour le 14 mars 2025.